Skip to content
AgewellAGEWELL · Q2 2026Get the Briefing

Agewell · Editorial policy

Editorial policy

The whole site sells one thing: a verdict you can trust at the moment you spend. These are the rules that protect it.

No pay-to-play

Nothing moves up the Index because a brand pays. Verdicts are written before any commercial conversation, and zero verdicts are sponsored. When our top pick has no affiliate program – as with the red light panel we rank first – we link it anyway and earn nothing.

Document-grade claims

We only claim what the documents can prove. Until a category has a real purchase behind it, we write "specs verified against manufacturer documentation and independent measurements; discrepancies flagged" – never "we bought it" or "our meter read X" unless we did.

A flag is never for sale

A FLAG or AVOID verdict never carries a commercial link, whatever the commission would have been. The flagged products on our category pages are credibility, not lost revenue.

Corrections and medical scope

We correct errors and date the change. Agewell is informational and is not medical advice; for peptides, medications, clinical protocols and any safety-sensitive decision, talk to a qualified clinician. Questions or corrections: hi@agewell.guide.

Updated 2026-06-12 · Questions? hi@agewell.guide

The Agewell Briefing

When a score moves or a claim fails the document check, you hear it here first.

One letter a week – what to buy, what to question, what to skip. No sponsors inside the letter, ever.

One email a week. Unsubscribe with one click.